Abstract

HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic.

Highlights

  • Information is limited, on how parameters such as QTc measured on a single- lead ECG can reliably substitute for 12-lead ECG information.[18,19]

  • Most health care centers have expanded use of telemedicine, with some reporting 100% transformation of in-person clinic visits to telemedicinebased visits in order to maintain care for non-COVID-19 patients, obviating their need to come to the hospital or clinic

  • cardiovascular implantable electronic device (CIED), wearable/mobile health, and clinical data can be integrated into the clinician workflow

Read more

Summary

Therapy for COVID-19 and potential electrical effects

No specific cure exists for COVID-19.28–30 Potential COVID19 therapies, especially hydroxychloroquine and azithromycin, are being investigated in ongoing trials and have been used off-label in many parts of the world. A recent statement from the US Food & Drug Administration (FDA) “cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems.” (This does not affect FDAapproved uses for malaria, lupus, and rheumatoid arthritis.)[51] Exceptions to this practice are acknowledged to occur in some regions, as these drugs have been used outside the United States without regulatory warnings Under these conditions, or when these drugs are maintained after hospital discharge, consumer mobile ECG devices capable of generating QTc measurements may be used. These ECGs are transmitted to a remote QTc monitoring site, where the QTc is assessed and monitored over the treatment period

The future
5: Boston
1: Patient Safety Authority
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.